Loading, please wait...
 Buprenorphine-Naloxone versus Extended-Release Naltrexone: A Comparison of Efficacy and SafetyThis Opioid Training Initiative course was developed to prepare healthcare professionals who work with clients with opioid use disorder. Through the course, participants will be able to describe the neurobiological processes involved in OUD, evaluate the efficacy and safety of two medications for OUD (MOUD) and analyze existing evidence for optimal MOUD selection.
The information in this course has been specifically tailored to meet the needs of clinicians practicing in Texas with a focus on regional trends, laws and regulations.
|
Lindsey J. Loera, Pharm.D.
PhARM Fellow, University of Texas at Austin College of Pharmacy
Clinical Pharmacists, CARAhealth Management, Inc
Dr. Loera graduated from The University of Texas at Austin College of Pharmacy in 2020 and is currently completing a two-year fellowship with the PhARM Program. In this role, she will develop an innovative clinical pharmacy practice at CARMAhealth and conduct statewide research exploring the pharmacist’s role in addiction treatment. She previously served as President of the Student Pharmacist Recovery Network and co-founded the Addiction Medicine Advanced Pharmacy Practice Experience.
DISCLOSURE: Dr. Loera has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.
 |
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.1 CEUs (1.00 contact hour) of continuing education credit. In order to receive 1.00 contact hour of CE credit, the participant must watch the video in its entirety, complete the online post-test, and complete online evaluation. Please make sure NABP profile and date of birth (month/year) are correct under learner's profile in this system. |
The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Long School of Medicine designates this material for a maximum of 1.0 AMA PRA Category 1 Credit™ .
Accreditation Statement: University of Texas at Austin School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Requirements for Successful Completion: To receive contact hours for this continuing education activity, the participant must sign in, attend the entire activity, pass the post-test with at least 70% correct answers, and complete and submit the evaluation form. Once successful completion has been verified, a “Certificate of Successful Completion” will be awarded for 1 contact hour. Learning outcome: Registered nurses should verbalize intent to change practice based on knowledge gained regarding the development and basic components of a buprenorphine program in an acute care hospital setting utilizing the effectiveness of interprofessional collaborations for the latest, evidence-based patient care. Conflicts of Interest: All activity planning committee members and presenters/authors/content reviewers have had their Conflict of Interest assessed, identified and resolved by the nurse planner. Disclosures required if applicable: Kirsten Mason receives grant/research support from Macromoltek. Joint Provider Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center through the joint providership of the University of Texas at Austin School of Nursing, The University of Texas at Austin School of Pharmacy, The University of Texas at Austin Hick School of Social Work, and the UT Health San Antonio Joe R. and Teresa Lozano Long School of Medicine Continuing Medical Education. University of Texas at Austin School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity expires June 18, 2023
The Office of Professional Development at The University of Texas at Austin Steve Hicks School of Social Work provides continuing education in accordance with the criteria and standards of the Texas Board of Social Workers, Licensed Professional Counselors, and Licensed Marriage and Family Therapists and Licensed Psychologist under Texas Administrative Code, Title 22, Part 34. § 781.509. Complaints about this program may be made to TSBSWE, 333 Guadalupe St., Tower 3, Room 900, Austin, TX 78701 • 512-305-7700 • 800-821-3205 • bhec.texas.gov/texas-state-board-of-social-worker-examiners/ 333 Guadalupe St, Tower 3, Room 900, Austin, TX 78701 • 512-305-7700 • 800-821-3205
| This project is funded by Texas Health & Human Services Texas Targeted Opioid Response. |
Buprenorphine-Naloxone versus Extended-Release Naltrexone: A Comparison of Efficacy and SafetyLindsey J. Loera, Pharm.D.
PhARM Fellow, University of Texas at Austin College of Pharmacy Clinical Pharmacists, CARAhealth Management, Inc
|
LEARNING OBJECTIVES
| This project is funded by Texas Health & Human Services Texas Targeted Opioid Response. |